Evidence map›Paper›PMID 41511082›Full record

ArticleJournal of virology2026

N-terminal acetylation controls multiple functional aspects of the influenza A virus ribonuclease PA-X.

Raecliffe E Daly, Cynthia Y Feng, Charles R Hesser, Idalia Myasnikov, Marta Maria Gaglia

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Raecliffe E DalyProgram in Cellular, Molecular and Developmental Biology, Tufts University Graduate School of Biomedical Sciences, Boston, Massachusetts, USA.
Cynthia Y FengInstitute for Molecular Virology and Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0009-0007-0712-5067
Charles R HesserInstitute for Molecular Virology and Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Idalia MyasnikovInstitute for Molecular Virology and Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Marta Maria GagliaInstitute for Molecular Virology and Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-1791-0663

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00017 · NIAID · EMORY UNIVERSITY · PI LOWEN, ANICE · 2021 to 2025
$27.3M
Molecular Mechanism of Action of the Influenza PA-X Host Shutoff ProteinR01AI137358 · NIAID · TUFTS UNIVERSITY BOSTON · PI GAGLIA, MARTA MARIA · 2018 to 2022
$2.0M
NIAID NIH HHS 75N93021C00017NIAID NIH HHS R01 AI137358
6 · The paper itself

Abstract

To counteract host antiviral responses, influenza A virus triggers a global reduction of cellular gene expression, a process termed "host shutoff." A key effector of influenza A virus host shutoff is the viral endoribonuclease PA-X, which degrades host mRNAs. While many of the molecular determinants of PA-X activity remain unknown, a previous study found that N-terminal acetylation of PA-X is required for its host shutoff activity upon ectopic expression. However, it remains unclear how this co-translational modification promotes PA-X activity. Here, we report that PA-X N-terminal acetylation has two functions-it promotes nuclear localization but is also needed directly for host shutoff. Moreover, these two functions can be separated based on whether acetylation occurs on the first amino acid, the initiator methionine, or the second amino acid following initiator methionine excision. Modification at either site is sufficient to ensure PA-X localization to the nucleus, whereas N-terminal acetylation of the initiator methionine is specifically required for normal PA-X host shutoff activity. We also demonstrate that PA-X N-terminal acetylation is needed for its activity during infection. Our studies thus uncover a multifaceted role for PA-X N-terminal acetylation in the regulation of this important immunomodulatory factor.IMPORTANCEInfluenza A viruses pose a significant threat to human health through seasonal epidemics and recurrent pandemics. Our immune and inflammatory responses have a key role in disease outcome. They clear the virus but can also cause lung damage. Influenza A viruses encode factors that modulate these responses, including PA-X, which destroys cellular mRNAs to control immune responses (a phenomenon called "host shutoff"). PA-X is modified with an acetylation at its N-terminus. This modification is needed for its activity, but it has remained unclear why. We show that PA-X N-terminal acetylation ensures that PA-X goes to the nucleus but also separately contributes to host shutoff activity. For host shutoff activity, the specific location of the modification matters, whereas for entry into the nucleus, it does not. These findings uncover how influenza A viruses exploit a widespread protein modification to support the activity of one of their important immunomodulatory proteins.

Indexed as

Influenza A virusViral Nonstructural ProteinsAcetylationAnimalsCell NucleusDogsHost-Pathogen InteractionsHumansProtein Processing, Post-TranslationalRepressor ProteinsPA-X protein, influenza A virusRepressor ProteinsViral Nonstructural Proteinshost shutoffinfluenza A virusN-terminal acetylationPA-X

Identifiers

PMID41511082
PMCPMC12911887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.